Humoral immunity to Ro52 is not associated with the Ro52 9571 C/T polymorphism in Australian patients with primary Sjögren's syndrome

Arthritis and Rheumatism

Volumn 48, Issue 11, 2003, Pages 3293-3294

  Lester, Sue ^a   Danda, Debashish ^b,c   Cavill, Dana ^d   Pile, Kevin ^e   Downie Doyle, Sarah ^b   Rischmueller, Maureen ^b  

^a HANSON INSTITUTE   (Australia)

^b QUEEN ELIZABETH HOSPITAL   (Australia)

^c CHRISTIAN MEDICAL COLLEGE   (India)

^d FLINDERS MEDICAL CENTRE   (Australia)

^e UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G; RHEUMATOID FACTOR;

ALLELE; ANTIBODY DETECTION; ARTICLE; AUSTRALIA; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DNA POLYMORPHISM; HUMAN; HUMORAL IMMUNITY; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SJOEGREN SYNDROME;

ANTIBODY FORMATION; AUTOANTIGENS; DNA PRIMERS; HLA-DR ANTIGENS; HUMANS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RIBONUCLEOPROTEINS; RNA, SMALL CYTOPLASMIC; SJOGREN'S SYNDROME; SOUTH AUSTRALIA;

EID: 0242663505     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.11309     Document Type: Article

References (12)

1. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, et al. Preliminary criteria for the classification of Sjögren's syndrome: results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993;36:340-7.
2. Jonsson R, Moen K, Vestrheim D, Szodoray P. Current issues in Sjögren's syndrome. Oral Dis 2002;8:130-40.
3. Tseng CE, Buyon JP. Neonatal lupus syndromes. Rheum Dis Clin North Am 1997;23:31-54.
4. Ohlsson M, Jonsson R, Brokstad KA. Subcellular redistribution and surface exposure of the Ro52, Ro60 and La48 autoantigens during apoptosis in human ductal epithelial cells: a possible mechanism in the pathogenesis of Sjögren's syndrome. Scand J Immunol 2002;56:456-69.
5. Tan EM. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989;44:93-151.
6. Beer RG, Rischmueller M, Coates T, Purcell AW, Keech CL, McCluskey J, et al. Nonprecipitating anti-La(SS B) autoantibodies in primary Sjögren's syndrome. Clin Immunol Immunopathol 1996;79:314-8.
7. McCluskey J, Farris AD, Keech CL, Purcell AW, Rischmueller M, Kinoshita G, et al. Determinant spreading: lessons from animal models and human disease. Immunol Rev 1998;164:209-29.
8. Rischmueller M, Lester S, Chen Z, Champion G, Van Den Berg R, Beer R, et al. HLA class II phenotype controls diversification of the autoantibody response in primary Sjögren's syndrome (pSS). Clin Exp Immunol 1998;111:365-71.
9. Gordon TP, Bolstad AI, Rischmueller M, Jonsson R, Waterman SA. Autoantibodies in primary Sjögren's syndrome: new insights into mechanisms of autoantibody diversification and disease pathogenesis. Autoimmunity 2001;34:123-32.
10. Nakken B, Jonsson R, Bolstad AI. Polymorphisms of the Ro52 gene associated with anti-Ro 52-kd autoantibodies in patients with primary Sjögren's syndrome. Arthritis Rheum 2001;44:638-46.
11. Chan EK, Di Donato F, Hamel JC, Tseng CE, Buyon JP. 52-kD SS-A/Ro: genomic structure and identification of an alternatively spliced transcript encoding a novel leucine zipper-minus autoantigen expressed in fetal and adult heart. J Exp Med 1995;182:983-92.
12. Nakken B, Jonsson R, Brokstad KA, Omholt K, Nerland AH, Haga HJ, et al. Associations of MHC class II alleles in Norwegian primary Sjögren's syndrome patients: implications for development of autoantibodies to the Ro52 autoantigen. Scand J Immunol 2001;54:428-33.